VIBERZI

This brand name is authorized in Canada, New Zealand, United States

Active ingredients

The drug VIBERZI contains one active pharmaceutical ingredient (API):

1 Eluxadoline UNII 45TPJ4MBQ1 - ELUXADOLINE

Eluxadoline is a locally acting, mixed mu opioid receptor (μOR) agonist and delta opioid receptor (δOR) antagonist. Eluxadoline is also an agonist at the kappa opioid receptor (κOR). Eluxadoline has demonstrated efficacy in normalizing GI transit and defecation in several models of stress induced or post GI inflammation-altered GI function in animals. Read about Eluxadoline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIBERZI Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07DA06		A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02460890, 02460904
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18681, 18682
Country: US	FDA, National Drug Code	Identifier(s): 61874-075, 61874-100